Nf2 Biosolutions
EIN 830940046 Public CharityAnnual Giving
$779K
11 grants · avg $260K/yr
public charity (Form 990), grant-level detail not in 990-PF database
$100K+/yr
local funder
capacity
$38K
typical mid grants · $17K–$65K
grant size
38%
supporter · 3/8 multi-year
repeat
8
Distinct Recipients
Application Information
Accepts Unsolicited Proposals
Unknown
Grant Size Distribution
Based on 11 grants on record
Minimum
$5K
25th Pctl
$17K
Median
$38K
Average
$71K
75th Pctl
$65K
Maximum
$394K
Geographic Distribution
Grants Awarded (11 total)
| Purpose | ||||
|---|---|---|---|---|
| Laboratory of Gary Brenner MD | Boston, MA | $394,000 | therapy for NF2 | 2020 |
| Mass Gen Development Office | Boston, MA | $100,000 | development of bacteriotherapy for NF2 | 2021 |
| Yale University | New Haven, CT | $72,702 | tumor imaging model | 2022 |
| Laboratory of Gary Brenner MD | Boston, MA | $57,500 | development of bacteriotherapy for NF2 | 2021 |
| Indiana University Research | Bloomington, IN | $47,007 | drug testing | 2021 |
| Institute for Cancer Research | Philadelphia, PA | $37,500 | research | 2022 |
| CHOP Research Institute | Philadelphia, PA | $23,724 | developing a tumor biobank for NF2 | 2021 |
| Mass Gen Development Office | Boston, MA | $20,000 | development of bacteriotherapy for NF2 | 2022 |
| Yale University | New Haven, CT | $13,254 | tumor imaging model | 2021 |
| CHOP Research Institute | Philadelphia, PA | $7,983 | developing a tumor biobank for NF2 | 2022 |
| University of California | Los Angeles, CA | $5,000 | research | 2022 |